APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →
This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →
If you haven’t already, don’t forget to download and share the 2023-2024 edition of our Snapshot of Pharmacy Compounding in America — a slick guide to the most important information and numbers that reflect the practice of pharmacy compounding in the US.
It’s perfect for sharing with policymakers, media, prescribers, and anyone else who could benefit from a primer on the practice.
The snapshot was made possible by the generous support of APC corporate patrons Fagron, Medisca, and PCCA.
